Company intelligence / Profile preview

BioMedPharmIS

Near Damascus, Rif Dimashq Governorate, Syriadbiosla.org ↗

Ownership: Private
Development stage: Other

Overview

BioMed Pharma entities in Syria, the Philippines, India, Canada, and Yemen operate as manufacturers or distributors of high-quality generic pharmaceuticals. The Syrian company focuses on chronic diseases with ISO-certified manufacturing. The Philippine entity distributes branded generics approved by local authorities. Indian operations supply APIs and vitamins to formulation companies. Canadian operations import/market generics/biosimilars for pharmacies. Yemeni operations specialize in cancer therapies.

Therapeutic areas: NeurologyInfectious DiseasesGastroenterologyEndocrinologyCardiovascular
Modalities: Small molecule
Industry: Biotech

Partnerships

Strategic tie-ups with major pharma manufacturers for API supply (India)

Beyond the preview

Go deeper on BioMedPharmIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMedPharmIS.

Explore the full profile